Insider Transactions in Q4 2023 at Viracta Therapeutics, Inc. (VIRX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2023
|
Mark Rothera President and CEO |
BUY
Open market or private purchase
|
Direct |
47,906
+32.39%
|
$0
$0.49 P/Share
|
|
Nov 30
2023
|
Mark Rothera President and CEO |
BUY
Open market or private purchase
|
Direct |
52,094
+50.0%
|
$0
$0.49 P/Share
|
|
Nov 28
2023
|
Daniel R. Chevallard CFO and COO |
SELL
Open market or private sale
|
Direct |
3,720
-3.63%
|
$0
$0.5 P/Share
|
|
Nov 25
2023
|
Daniel R. Chevallard CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,889
+6.3%
|
-
|
|
Nov 25
2023
|
Roger Pomerantz |
BUY
Exercise of conversion of derivative security
|
Direct |
9,034
+9.09%
|
-
|
|
Nov 25
2023
|
Ivor Royston |
BUY
Exercise of conversion of derivative security
|
Direct |
25,219
+3.3%
|
-
|